A Case of Pregnancy Complicated by Non-Hodgkin's Lymphoma and Idiopathic Thrombocytopenic Purpura
Jia-Lue Wang,Yangyu Zhao,Yuan-hui Jiang
DOI: https://doi.org/10.3760/cma.j.issn.0366-6999.20130419
2013-01-01
Abstract:To the editor: Pregnancy complicated by non-Hodgkin's lymphoma (NHL) has rarely been reported. It has been estimated that about 0.76% (0-1.8%) of NHL cases are accompanied by idiopathic thrombocytopenic purpura (ITP). There are few reports in the medical literature of pregnancy complicated by both NHL and ITP. Here we reported a case. A 45-year-old pregnant woman at gestational week 35 was transferred to hospital on February 25, 2011 because of nausea and vomiting. The patient had been diagnosed with ITP by bone marrow biopsy 22 years ago. She had been treated with hormone therapy and platelet (PLT) counts had remained around 50 ×109/L. At gestational week 17, her PLT count was 86× 109/L, white blood cell (WBC) and hemoglobin (HGB) level were normal, without bleeding tendency. During pregnancy her PLT counts ranged from 54 × 109/L to 86 × 109/L. At admission her blood pressure had increased to 145/100 mmHg. Examination revealed twin pregnancy with both fetal heart rates normal. Laboratory testing revealed: WBC 12.80 × 109/L, neutrophil percentage 60.9%, HGB 115 g/L, PLT 7 × 109/L, Ret 3.07%, ALT 38 U/L, T-Bil 40.3 μmol/L, ALB 27.4 g/L, AST 254 U/L, LDH 5560 U/L, BUN 7 mmol/L, Cr 112 μmol/L, blood ammonia 59 U/L, normal coagulation, 1+ urine protein. Ultrasound examination revealed: the left lobe of the liver was heterogeneously echogenic, multiple enlarged lymph nodes in the hepatic portal area and splenomegaly. Initial diagnoses included severe preeclampsia, HELLP syndrome, and thrombocytopenia. Caesarean section was performed on February 26, 2011. Before operation the PLT level was 87 × 109/L after infusion of 3U PLT. Despite the recovering of the patient on postoperative days, complete blood cell counts kept decrease: WBC from 14.60 × 109/L to 2.60 × 109/L, HGB from 103 to 74 g/L, and PLT from 75 to 15 × 109/L. Treatments including RBC and PLT transfusion, intravenous immunoglobulin γ, and oral methylprednisolone were adopted. RF, ANA and Immunoglobulin were normal. The result of bone marrow biopsy which performed on March 2 revealed active proliferation, increased megakaryocytes (total 30: transitional 30%, bare nucleus 70%), decreased PLT, and 10.3% unclassified cells. However, the patient declined further treatment and insisted on discharge. On March 15, she was transferred to hospital because of fever (38°C) accompanied by cough, and dyspnea for 4 days. Diagnoses include severe pneumonia, type I respiratory failure, pancytopenia, and suspected hematological malignancy. Laboratory testing revealed: WBC 2.09 × 109/L, neutrophil percentage 13.4%, RBC 1.50 × 1012/L, HGB 48 g/L, PLT 2 × 109/L, and normal liver and kidney function. Chest radiographs suggested diffuse interstitial lung disease of unknown origin. The patient was treated with biapenem, immunoglobulin γ, granulocyte colony-stimulating factor, interleukin-11, infusion of PLT and red blood cells. Serum ferritin test, triglyceride, EBV-IgM, and coagulation tests were performed. During the treatment her temperature persistently increased, WBC varied between 0.5 × 109/L and 1.2 × 109/L, and PLT decreased gradually (42 × 109/L→24 × 109/L→15 × 109/L→7 × 109/L). The result of bone marrow biopsy performed on March 21 suggested large B-cell lymphoma. The symptoms of dyspnea and hypoxemia were considered likely to be caused by lymphoma infiltrating the lungs, with secondary infection and edema. On March 23, a chemotherapy regimen consisting of 2 mg vincristine and 80 mg methylprednisolone was given. However, her condition kept deteriorating and she died on March 24 from multiple organ failure. Subsequent pathological examination revealed non-Hodgkin's lymphoma (NHL) that was diffuse large B-cell lymphoma, unspecified, based on the WHO classification system. It has been reported that the type of NHL that occurs during pregnancy is usually diffuse large B-cell lymphoma, and the reproductive organs are often involved. This might be related to the hormone-dependent growth of the tumor and the hyperplasia of these organs during pregnancy. However, the fetus and the placenta are rarely affected. The nonspecific symptoms of NHL, such as fatigue, nausea, and vomiting, can overlap with the normal physiological reactions to pregnancy. In addition, both pregnant women and their obstetricians are reluctant to have radiological and invasive examinations during pregnancy. Therefore, the diagnosis of NHL in pregnancy is often delayed. NHL is highly heterogeneous and individualized treatment taking into consideration the clinical stage and pathological type of the disease, the gestational week, and pregnancy-related risks is recommended.2 Simultaneous NHL and ITP has rarely been reported. ITP prior to NHL responds well to hormones, high doses of immunoglobulin, and splenectomy. Clinical remission is often achieved for these patients after NHL treatment. In conclusion, pregnancy complicated by NHL has nonspecific symptoms. Invasive NHL in pregnancy is often catastrophic; therefore, clinicians should be well informed about this condition in order to improve its diagnosis and treatment.